STOCK TITAN

Motus GI Scheduled to Present at Investor Conferences in September 2020

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences
Rhea-AI Summary

Motus GI Holdings, Inc. (NASDAQ: MOTS), a medical technology firm, announced its participation in two upcoming virtual investor conferences. The H.C. Wainwright 22nd Annual Global Investment Conference will take place on September 15, 2020, at 2:00 PM ET, accessible via webcast. Subsequently, the Oppenheimer Fall Healthcare Life Sciences & MedTech Summit is scheduled for September 22, 2020, at 3:20 PM ET. Motus GI focuses on endoscopy solutions that enhance clinical outcomes and cost-efficiency in gastrointestinal condition management.

Positive
  • None.
Negative
  • None.

FORT LAUDERDALE, Fla., Sept. 10, 2020 (GLOBE NEWSWIRE) -- Motus GI Holdings, Inc., (NASDAQ: MOTS) ("Motus GI" or the "Company"), a medical technology company providing endoscopy solutions that improve clinical outcomes and enhance the cost-efficiency associated with the diagnosis and management of gastrointestinal conditions, announced today that its management team is scheduled to be presenting at the following upcoming virtual investor conferences:

  • H.C. Wainwright 22nd Annual Global Investment Conference – Presenting on Tuesday, September 15, 2020 at 2:00 p.m. Eastern Time. The presentation will be accessible via a live and archived webcast at https://wsw.com/webcast/hcw7/mgh/1464380 or the Events page on the Company’s website, www.motusgi.com

  • Oppenheimer Fall Healthcare Life Sciences & MedTech Summit – Presenting on Tuesday, September 22, 2020 at 3:20 p.m. Eastern Time. The presentation will be accessible via a live and archived webcast at https://wsw.com/webcast/oppenheimer5/mgh/2474460 or the Events page on the Company’s website, www.motusgi.com

About Motus GI

Motus GI Holdings, Inc. is a medical technology company, with subsidiaries in the U.S. and Israel, providing endoscopy solutions that improve clinical outcomes and enhance the cost-efficiency associated with the diagnosis and management of gastrointestinal conditions.

For more information, visit www.motusgi.com and connect with the Company on Twitter, LinkedIn and Facebook.

Investor Contact:
Bob Yedid
LifeSci Advisors
(646) 597-6989
bob@lifesciadvisors.com


FAQ

When is Motus GI presenting at the H.C. Wainwright conference?

Motus GI is scheduled to present on September 15, 2020, at 2:00 PM ET.

What is the date of the Oppenheimer Fall Healthcare Life Sciences & MedTech Summit?

The Oppenheimer Fall Healthcare Life Sciences & MedTech Summit will be held on September 22, 2020.

What is the focus of Motus GI Holdings, Inc.?

Motus GI specializes in medical technology, providing endoscopy solutions for gastrointestinal conditions.

Where can I watch the Motus GI presentations?

The presentations can be accessed via live and archived webcasts on Motus GI's website and event pages.

MOTUS GI HOLDINGS INC

OTC:MOTS

MOTS Rankings

MOTS Latest News

MOTS Stock Data

435.11k
6.33M
0.9%
0.01%
0.45%
Medical Devices
Surgical & Medical Instruments & Apparatus
Link
United States of America
FT. LAUDERDALE